摘要
视网膜母细胞瘤（RB）和视网膜母细胞瘤基因（Rb）一直是多个学科研究的热点,近年来在RB发病机制和临床治疗等方面的研究均取得长足进步,但也面临更多难题。今后我国RB研究应加强与国际学术界的交流,加强各研究单位和不同学科间的合作,充分利用病例多的优势,争取在RB诊断、治疗和发病机制研究方面做出成果。
Despite its low incidence, retinoblastoma and its related gene （Rb gene） have attracted some of the most brilliant minds in medicine and biology fields over the past years. Great advances have been achieved in the tumoregenesis mechanism and clinical management of retinoblastoma recently. However as always, more questions arise from those results. In order to improve retinoblastoma research in China, we need to strengthen the communication and cooperation with different countries, different institutes and disciplines, and utilize the great resources of retinoblastoma patients in China.
出处
《中华眼底病杂志》
CAS
CSCD
北大核心
2007年第5期310-313,共4页
Chinese Journal of Ocular Fundus Diseases
